Abstract
Exocarpium Citri Grandis is a famous genuine regional drug in Guangdong province, which contains flavonoids, volatile oils, polysaccharides, curmarins and other effective components. In vivo and in vitro experiments have proved that it has many pharmacological actions, such as expelling phlegm and relieving cough, anti-inflammation, anti-oxidation, lowering blood glucose and lipids, protecting myocardium and so on. In order to better control the quality of tangerine and explore its potential pharmacological action, this paper reviews the research progress of Exocarpium Citri Grandis from two aspects of chemical composition and pharmacological action at home and abroad in recent years, and its applications in clinic and food industry are prospected.
Publisher
Darcy & Roy Press Co. Ltd.
Reference52 articles.
1. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China[M]. Beijing: 2020.
2. Zhou Xinhua, Deng Yun. Research progress of extraction and determination methods of flavonoid Compounds in exocarpium[J]. Value Engineering. Vol. 35 (2016) No. 20, p. 191-192.
3. Zhong Gang, Chen Dong. Research progress on mechanism of flavonoids in fat metabolism[J]. Chinese Journal of Animal Nutrition. Vol. 34 (2022) No. 6, p. 1-12.
4. Chen Yilu, Xu Menglan, Deng Jianshan, et al. Pulsed electric field extraction of flavonoids from Exocarpium Citri grandis and its antioxidant activity detection[J]. Journal of Hunan Agricultural University (Natural Sciences). Vol. 47 (2021) No. 3, p. 305-311.
5. Ying Peng, Hu Mengjun, Lu Qi, et al. Flavonoids derived from Exocarpium Citri Grandis inhibit LPS-induced inflammatory response via suppressing MAPK and NF-κB signalling pathways[J]. Food and Agricultural Immunology. Vol. 30(2019) No. 1, p. 564-580.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献